Skip to main content
. 2015 Mar 9;56(3):568–576. doi: 10.1093/jrr/rrv001

Fig. 2.

Fig. 2.

Parameters in patients with and without adverse events of Grade ≥2. All parameters were significantly higher in patients with late adverse events of Grade ≥2. Bars show the median and 95% CI. Horizontal bars show cut-off lines calculated from ROC curves.